Large-scale preparation of biologically active measles virus haemagglutinin expressed by attenuated vaccinia virus vectors

Microbes and Infection

Volumn 4, Issue 10, 2002, Pages 1035-1044

  Kidokoro, Minoru ^a,b   Aoki, Atsuko ^a,b   Horiuchi, Kiyoshi ^a   Shida, Hisatoshi ^c  

^a Chiba Serum Institute   (Japan)

^b CHIBA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Haemagglutinin; Histidine tag; Measles; Promoter; Vaccinia

Indexed keywords

HEMAGGLUTININ; HYBRID PROTEIN; MEASLES ANTIBODY; VIRUS PROTEIN; VIRUS VECTOR;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CELL FUSION; CELL LYSATE; CELL SURFACE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMADSORPTION; HUMAN; HUMAN CELL; IMMUNITY; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SERODIAGNOSIS; SYNTHESIS; VACCINIA VIRUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC VECTORS; HEMAGGLUTINATION TESTS; HEMAGGLUTININS, VIRAL; HUMANS; MEASLES VIRUS; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; VACCINIA VIRUS; VIRAL FUSION PROTEINS;

MEASLES VIRUS; VACCINIA VIRUS;

EID: 0036676091     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01627-1     Document Type: Article

References (43)

1. Cloning vectors derived from animal viruses
2. Baculovirus vectors for expression of foreign genes
3. Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus
4. Vaccinia virus: A selectable eukaryotic cloning and expression vector
5. Vaccinia virus expression vectors
6. Vaccinia virus: A tool for research and vaccine development
7. Properties of Attenuated Mutant of Vaccinia Virus LC16m8, Derived from Lister Strain
8. Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5 kDa protein, and hemagglutinin gene promoters support high levels of expression
9. Poxviruses as expression vectors
10. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes
11. Intracellular processing and antigenic maturation of measles virus hemagglutinin protein
12. Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein
13. The human CD46 molecule is a receptor for measles virus (Edmonston strain)
14. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
15. Moesin: A cell membrane protein linked with susceptibility to measles virus infection
16. (CDw150) is a cellular receptor for measles virus
17. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding
18. Measles virus: Both the haemagglutinin and fusion glycoproteins are required for fusion
19. Measles virus glycoproteins: Studies on the structure and interaction of the haemagglutinin and fusion proteins
20. The role of N-glycosylation in cell fusion induced by a vaccinia recombinant virus expressing both measles virus glycoproteins
21. Measles active and passive immunity in a worldwide perspective
22. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis
23. Cytotoxic T cells in paramyxovirus infections of humans
24. Cytotoxic T lymphocyte responses against measles virus
25. Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults
26. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children
27. Measles antibody: Reevaluation of protective titers
28. Correlation between epitopes on hemagglutinin of measles virus and biological activities: Passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity
29. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity
30. Purification and characterization of measles virus haemagglutinin protein G
31. Purification of measles virus H polypeptide and of F polypeptide
32. Haemagglutinin of measles virus: Purification and storage with preservation of biological and immunological properties
33. Isolation of the measles virus hemagglutinin protein in a soluble form by protease digestion
34. Immune reactivity of purified hemagglutinin of measles virus
35. Purification, morphology and antigenic characterization of measles virus envelope components
36. Development and evaluation of the TD97 measles virus vaccine
37. Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirusvector containing the beta-galactosidase gene
38. Characterization of baculovirus-expressed hemagglutinin and fusion glycoproteins of the attenuated measles virus strain AIK-C
39. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus
40. Performance and reliability of the Enzygnost measles enzyme-linked immunosorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic
41. The carboxy-terminal 18 amino acids of the measles virus hemagglutinin are essential for its biological function
42. Nonreplicating vaccinia vector efficiently expresses recombinant genes
43. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene